Hackett vs TSS
HCKT and TSSI side by side, both in management and public relations services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HCKT and TSSI compare
Hackett is the larger company, worth 2.1 times as much as TSS ($326M against $159M).
On earnings, TSS is cheaper: it trades at 11.7× trailing earnings, against 20.2× for Hackett.
Hackett grew revenue faster over the last twelve months (−9.1% versus −26.5% for TSS).
TSS keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with 5.9% at Hackett.
Hackett pays a dividend yielding 3.7%; TSS does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HCKT | TSSI |
|---|---|---|
| Size and price | ||
| Market cap | $326M | $159M |
| Share price | $13.11 | $5.63 |
| Change, 1 year | −28.9% | −34.8% |
| Change, 5 years | −38.0% | 950% |
| Beta (5Y) | 0.48 | 2.62 |
| Employees | 1,503 | 286 |
| StockData Score | ||
| Total score | 17 | 17 |
| Valuation score | 3 | 6 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 5 | 6 (better) |
| Health score | 4 (better) | 3 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 20.2× | 11.7× (better) |
| P/S | 1.1× | 0.8× (better) |
| P/B | 4.8× | 2.0× (better) |
| EV/EBITDA | 12.6× (better) | 20.9× |
| P/FCF | 10.5× | – |
| FCF yield | 9.6% (better) | −13.2% |
| Fair value | $14.46 | $10.34 |
| Margin of safety | 9.3% | 45.5% (better) |
| Growth | ||
| Revenue growth (TTM) | −9.1% (better) | −26.5% |
| Revenue growth, 5Y average | 5.0% | 40.4% (better) |
| Net income growth (TTM) | −0.74% | 59.3% (better) |
| EPS growth (TTM) | 8.3% | 37.1% (better) |
| EPS growth, 5Y average | 22.0% | – |
| Profitability | ||
| Gross margin | 41.3% (better) | 17.0% |
| Operating margin | 10.9% (better) | 2.0% |
| Net margin | 5.9% | 7.4% (better) |
| FCF margin | 10.9% (better) | −10.9% |
| Return on equity | 17.9% | 32.0% (better) |
| Return on invested capital | 14.1% | 48.3% (better) |
| Financial health | ||
| Debt / equity | 1.19 | 0.20 (better) |
| Net debt / EBITDA | 2.14 (better) | −10.05 |
| Interest coverage | 9.3× | – |
| Current ratio | 1.94 (better) | 1.66 |
| Altman Z-score | 4.04 (better) | 2.13 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.7% | – |
| Payout ratio | 74.8% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 4.8% | – |
| Buyback yield | 20.1% (better) | 2.0% |
| Shareholder yield | 23.8% (better) | 2.0% |
| Ownership | ||
| Held by institutions | 84.5% | 46.3% |
| Held by insiders | 12.6% | 16.8% |
| Insider net buying, 12 months | – | −$8.9M |
| Short interest, % of float | 5.6% | 18.1% |
Go deeper
- HCKT stock overview
- HCKT income statement
- HCKT valuation and score
- TSSI stock overview
- TSSI income statement
- TSSI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.